Medical Developments International Limited (ASX: MVP) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Medical Developments International Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Medical Developments International Limited (ASX: MVP)
Latest News
Share Market News
Why the Medical Developments share price is up 50% since October
Share Market News
ALL ORDINARIES finishes higher Friday: 8 ASX shares you missed
Share Gainers
Medical Developments International share price higher on Russia news
Share Gainers
Why FAR, Medical Developments, MGC Pharma, & Western Areas are pushing higher
52-Week Highs
Why Fortescue and these ASX shares just zoomed to 52-week highs
Share Gainers
Why Catapult, Medical Developments, Panoramic, & Western Areas are pushing higher
Share Market News
ALL ORDINARIES finishes lower Thursday: 8 ASX shares you missed
Share Gainers
Why Hansen, MDI, Monadelphous, & Titomic shares are racing higher today
Share Gainers
Medical Developments International shares surge higher on China news
Share Market News
Why the Medical Developments share price charged higher in October
Share Market News
Medical Developments International announces agreement with CSIRO
Share Gainers
Why Amaysim, Medical Developments, Treasury Wine, & Volpara stormed higher
Frequently Asked Questions
-
Medical Developments International has not paid a Dividend since 2019.
-
Medical Developments International Ltd listed on the ASX on 15 December 2003.
MVP ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Medical Developments International Limited
Medical Developments International Ltd (ASX: MVP) is an Australian- based pharmaceutical company. It manufactures and distributes pharmaceutical drugs covering pain management, asthma, and resuscitation, as well as medical and veterinary equipment.
The company has three business units: pharmaceuticals, medical devices, and veterinary products. The majority of its revenue comes from its pharmaceuticals segment which produces and sells the pain relief drug Penthrox within Australia, New Zealand, and the United Kingdom, as well as some sales in other countries.
